A patient who combined tadalafil (Cialis) and sildenafil (Viagra) 28 days ago now has persistent penile firmness, discoloration, and difficulty maintaining erections with variable size—could this be a vein clot or phlebitis, and what is the appropriate management?

Urgent Urologic Evaluation for Suspected Penile Vein Thrombosis

This patient most likely has partial segmental thrombosis of the corpus cavernosum (PSTCC), not priapism, and requires immediate penile duplex Doppler ultrasound and MRI to confirm the diagnosis, followed by systemic anticoagulation if thrombosis is confirmed 1.

Clinical Reasoning

Your suspicion of a vein clot or phlebitis is correct. The clinical presentation—persistent firmness 28 days after combining PDE5 inhibitors, variable penile size, discoloration, and difficulty maintaining erections without true rigid priapism—strongly suggests PSTCC rather than ischemic priapism. The key distinguishing features are:

• Duration: 28 days is far too long for untreated ischemic priapism (which causes permanent damage within days)
• Variable rigidity: The penis changes size and has periods of softness, unlike the sustained rigid erection of true priapism
• Preserved erectile capacity: He can still achieve erections, though impaired
• Discoloration: Suggests venous thrombosis rather than arterial insufficiency

Immediate Diagnostic Workup

Order these imaging studies urgently:

1. Penile duplex Doppler ultrasound - First-line to assess blood flow and identify thrombosis 2, 1
2. MRI of the penis - Gold standard for visualizing segmental thrombosis in the corpus cavernosum 1
3. CT if MRI unavailable - Can demonstrate thrombotic changes 1

Look for these specific findings:

• Hypoechoic or heterogeneous areas in the proximal corpus cavernosum on ultrasound
• Segmental filling defects indicating thrombus
• Asymmetric cavernosal appearance

Management Algorithm

If PSTCC is Confirmed:

Initiate systemic anticoagulation immediately 1. The documented case of PSTCC associated with PDE5 inhibitor use was successfully treated conservatively with anticoagulation, resulting in complete resolution without long-term erectile dysfunction 1.

Anticoagulation protocol:

• Start therapeutic anticoagulation (LMWH or direct oral anticoagulant)
• Duration: Typically 3-6 months, guided by repeat imaging
• Monitor for resolution with follow-up ultrasound at 4-6 weeks

If Imaging Shows No Thrombosis:

Consider alternative diagnoses including:

• Peyronie's disease (fibrotic changes from trauma)
• Cavernosal fibrosis from the drug interaction
• Venous leak syndrome

Critical Drug Interaction Warning

The combination of tadalafil and sildenafil is explicitly contraindicated and dangerous 3, 4. Both FDA labels warn:

• Never combine PDE5 inhibitors - The safety and efficacy of combinations have not been studied 3
• Additive vasodilatory effects can cause severe hypotension 3, 4
• Prolonged erections >4 hours require immediate medical attention 3, 4
• Recent case reports document refractory priapism requiring penile prosthesis from PDE5 inhibitor interactions 5

The patient's initial "unusually firm shaft" on day 1 likely represented a prolonged erection from the drug combination that evolved into thrombotic complications.

Why This Is NOT Classic Priapism

The AUA/SMSNA guidelines define acute ischemic priapism as a fully rigid erection >4 hours with abnormal blood gases 2. This patient's presentation differs fundamentally:

• Partial rigidity that varies with position and time
• 28-day duration without progression to complete erectile failure
• Maintained erectile capacity (priapism causes permanent ED within days if untreated) 2

The guidelines specifically note that "men with prolonged erections that are not fully rigid are less likely to progress to acute ischemic priapism" 6.

Prognosis and Follow-up

Good news: The single documented case of PSTCC from PDE5 inhibitor use had complete resolution with anticoagulation and no long-term erectile dysfunction 1. However, this requires:

• Prompt diagnosis and treatment initiation
• Compliance with anticoagulation
• Avoidance of all PDE5 inhibitors during treatment
• Close urologic follow-up

Counsel the patient:

• Never combine PDE5 inhibitors again - this is off-label and dangerous
• Single-agent PDE5 inhibitor therapy may be reconsidered after complete resolution, but only under close supervision
• The thrombosis likely resulted from the synergistic vasodilatory effects causing venous stasis

Common Pitfalls to Avoid

1. Don't dismiss this as benign - Untreated thrombosis can lead to permanent erectile dysfunction
2. Don't treat as priapism - Corporal aspiration and phenylephrine injections are inappropriate here 6, 2
3. Don't delay imaging - Clinical diagnosis alone is insufficient; you need objective confirmation
4. Don't restart PDE5 inhibitors until complete resolution is documented and only with single-agent therapy at appropriate dosing